nodes	percent_of_prediction	percent_of_DWPC	metapath
Mifepristone—ABCC1—Lamivudine—hepatitis B	0.436	0.806	CbGbCtD
Mifepristone—ABCB1—Lamivudine—hepatitis B	0.105	0.194	CbGbCtD
Mifepristone—Musculoskeletal chest pain—Telbivudine—hepatitis B	0.0188	0.0559	CcSEcCtD
Mifepristone—Flank pain—Telbivudine—hepatitis B	0.0181	0.0538	CcSEcCtD
Mifepristone—AR—semen—hepatitis B	0.0103	0.263	CbGeAlD
Mifepristone—Blood triglycerides increased—Lamivudine—hepatitis B	0.00627	0.0187	CcSEcCtD
Mifepristone—Pain in extremity—Telbivudine—hepatitis B	0.00529	0.0157	CcSEcCtD
Mifepristone—Cramp muscle—Telbivudine—hepatitis B	0.00476	0.0142	CcSEcCtD
Mifepristone—Nasopharyngitis—Telbivudine—hepatitis B	0.00473	0.0141	CcSEcCtD
Mifepristone—Muscular weakness—Telbivudine—hepatitis B	0.00467	0.0139	CcSEcCtD
Mifepristone—Sinusitis—Adefovir Dipivoxil—hepatitis B	0.00454	0.0135	CcSEcCtD
Mifepristone—Oedema peripheral—Entecavir—hepatitis B	0.00439	0.0131	CcSEcCtD
Mifepristone—Connective tissue disorder—Adefovir Dipivoxil—hepatitis B	0.00427	0.0127	CcSEcCtD
Mifepristone—Mental disorder—Entecavir—hepatitis B	0.0039	0.0116	CcSEcCtD
Mifepristone—Malnutrition—Entecavir—hepatitis B	0.00388	0.0115	CcSEcCtD
Mifepristone—Malnutrition—Adefovir Dipivoxil—hepatitis B	0.00378	0.0113	CcSEcCtD
Mifepristone—Back pain—Adefovir Dipivoxil—hepatitis B	0.00366	0.0109	CcSEcCtD
Mifepristone—Connective tissue disorder—Telbivudine—hepatitis B	0.0036	0.0107	CcSEcCtD
Mifepristone—Mediastinal disorder—Telbivudine—hepatitis B	0.0033	0.00981	CcSEcCtD
Mifepristone—Unspecified disorder of skin and subcutaneous tissue—Entecavir—hepatitis B	0.00328	0.00976	CcSEcCtD
Mifepristone—Myalgia—Adefovir Dipivoxil—hepatitis B	0.00322	0.00959	CcSEcCtD
Mifepristone—Unspecified disorder of skin and subcutaneous tissue—Adefovir Dipivoxil—hepatitis B	0.0032	0.00952	CcSEcCtD
Mifepristone—Malnutrition—Telbivudine—hepatitis B	0.00319	0.00948	CcSEcCtD
Mifepristone—Infection—Entecavir—hepatitis B	0.00315	0.00936	CcSEcCtD
Mifepristone—Thirst—Lamivudine—hepatitis B	0.00313	0.00932	CcSEcCtD
Mifepristone—Nervous system disorder—Entecavir—hepatitis B	0.0031	0.00924	CcSEcCtD
Mifepristone—Back pain—Telbivudine—hepatitis B	0.00308	0.00917	CcSEcCtD
Mifepristone—Skin disorder—Entecavir—hepatitis B	0.00308	0.00915	CcSEcCtD
Mifepristone—Muscle spasms—Telbivudine—hepatitis B	0.00306	0.00911	CcSEcCtD
Mifepristone—Hypoglycaemia—Lamivudine—hepatitis B	0.00306	0.00909	CcSEcCtD
Mifepristone—Nervous system disorder—Adefovir Dipivoxil—hepatitis B	0.00303	0.00901	CcSEcCtD
Mifepristone—Skin disorder—Adefovir Dipivoxil—hepatitis B	0.003	0.00893	CcSEcCtD
Mifepristone—Ill-defined disorder—Telbivudine—hepatitis B	0.00296	0.0088	CcSEcCtD
Mifepristone—Anorexia—Adefovir Dipivoxil—hepatitis B	0.00294	0.00876	CcSEcCtD
Mifepristone—Malaise—Telbivudine—hepatitis B	0.00287	0.00855	CcSEcCtD
Mifepristone—Insomnia—Entecavir—hepatitis B	0.00286	0.00852	CcSEcCtD
Mifepristone—Somnolence—Entecavir—hepatitis B	0.00281	0.00837	CcSEcCtD
Mifepristone—Musculoskeletal discomfort—Adefovir Dipivoxil—hepatitis B	0.00281	0.00837	CcSEcCtD
Mifepristone—CYP3A5—blood plasma—hepatitis B	0.00274	0.0701	CbGeAlD
Mifepristone—Gastrointestinal disorder—Entecavir—hepatitis B	0.00273	0.00813	CcSEcCtD
Mifepristone—Fatigue—Entecavir—hepatitis B	0.00273	0.00812	CcSEcCtD
Mifepristone—NR3C1—blood plasma—hepatitis B	0.00272	0.0695	CbGeAlD
Mifepristone—Arthralgia—Telbivudine—hepatitis B	0.00271	0.00807	CcSEcCtD
Mifepristone—Myalgia—Telbivudine—hepatitis B	0.00271	0.00807	CcSEcCtD
Mifepristone—Unspecified disorder of skin and subcutaneous tissue—Telbivudine—hepatitis B	0.00269	0.00802	CcSEcCtD
Mifepristone—Cramp muscle—Lamivudine—hepatitis B	0.00269	0.00799	CcSEcCtD
Mifepristone—Decreased appetite—Adefovir Dipivoxil—hepatitis B	0.00269	0.00799	CcSEcCtD
Mifepristone—Discomfort—Telbivudine—hepatitis B	0.00268	0.00797	CcSEcCtD
Mifepristone—Gastrointestinal disorder—Adefovir Dipivoxil—hepatitis B	0.00267	0.00793	CcSEcCtD
Mifepristone—Nasopharyngitis—Lamivudine—hepatitis B	0.00267	0.00793	CcSEcCtD
Mifepristone—Muscular weakness—Lamivudine—hepatitis B	0.00263	0.00782	CcSEcCtD
Mifepristone—Gastrointestinal pain—Entecavir—hepatitis B	0.00259	0.0077	CcSEcCtD
Mifepristone—Nervous system disorder—Telbivudine—hepatitis B	0.00255	0.00759	CcSEcCtD
Mifepristone—Skin disorder—Telbivudine—hepatitis B	0.00253	0.00751	CcSEcCtD
Mifepristone—Gastrointestinal pain—Adefovir Dipivoxil—hepatitis B	0.00253	0.00751	CcSEcCtD
Mifepristone—Abdominal pain—Entecavir—hepatitis B	0.0025	0.00745	CcSEcCtD
Mifepristone—Body temperature increased—Entecavir—hepatitis B	0.0025	0.00745	CcSEcCtD
Mifepristone—Body temperature increased—Adefovir Dipivoxil—hepatitis B	0.00244	0.00726	CcSEcCtD
Mifepristone—Abdominal pain—Adefovir Dipivoxil—hepatitis B	0.00244	0.00726	CcSEcCtD
Mifepristone—Musculoskeletal discomfort—Telbivudine—hepatitis B	0.00237	0.00705	CcSEcCtD
Mifepristone—Insomnia—Telbivudine—hepatitis B	0.00235	0.007	CcSEcCtD
Mifepristone—Asthenia—Entecavir—hepatitis B	0.00227	0.00676	CcSEcCtD
Mifepristone—Gastrointestinal disorder—Telbivudine—hepatitis B	0.00225	0.00668	CcSEcCtD
Mifepristone—Fatigue—Telbivudine—hepatitis B	0.00224	0.00667	CcSEcCtD
Mifepristone—CYP3A7—liver—hepatitis B	0.00223	0.057	CbGeAlD
Mifepristone—Pain—Telbivudine—hepatitis B	0.00222	0.00662	CcSEcCtD
Mifepristone—Asthenia—Adefovir Dipivoxil—hepatitis B	0.00222	0.00659	CcSEcCtD
Mifepristone—Pruritus—Adefovir Dipivoxil—hepatitis B	0.00219	0.0065	CcSEcCtD
Mifepristone—Diarrhoea—Entecavir—hepatitis B	0.00217	0.00644	CcSEcCtD
Mifepristone—Sinusitis—Lamivudine—hepatitis B	0.00216	0.00641	CcSEcCtD
Mifepristone—Feeling abnormal—Telbivudine—hepatitis B	0.00214	0.00638	CcSEcCtD
Mifepristone—Gastrointestinal pain—Telbivudine—hepatitis B	0.00213	0.00633	CcSEcCtD
Mifepristone—PGR—Nuclear Receptors—HNF4A—hepatitis B	0.00212	0.0254	CbGpPWpGaD
Mifepristone—Diarrhoea—Adefovir Dipivoxil—hepatitis B	0.00211	0.00629	CcSEcCtD
Mifepristone—Dizziness—Entecavir—hepatitis B	0.00209	0.00623	CcSEcCtD
Mifepristone—Body temperature increased—Telbivudine—hepatitis B	0.00206	0.00612	CcSEcCtD
Mifepristone—Abdominal pain—Telbivudine—hepatitis B	0.00206	0.00612	CcSEcCtD
Mifepristone—CYP3A4—blood plasma—hepatitis B	0.00205	0.0526	CbGeAlD
Mifepristone—Connective tissue disorder—Lamivudine—hepatitis B	0.00203	0.00603	CcSEcCtD
Mifepristone—CYP2D6—blood plasma—hepatitis B	0.00202	0.0517	CbGeAlD
Mifepristone—Vomiting—Entecavir—hepatitis B	0.00201	0.00599	CcSEcCtD
Mifepristone—PGR—Validated nuclear estrogen receptor alpha network—NR0B2—hepatitis B	0.00201	0.0242	CbGpPWpGaD
Mifepristone—Rash—Entecavir—hepatitis B	0.002	0.00594	CcSEcCtD
Mifepristone—Dermatitis—Entecavir—hepatitis B	0.00199	0.00593	CcSEcCtD
Mifepristone—PGR—Cellular roles of Anthrax toxin—IL18—hepatitis B	0.00199	0.0239	CbGpPWpGaD
Mifepristone—Headache—Entecavir—hepatitis B	0.00198	0.0059	CcSEcCtD
Mifepristone—Vomiting—Adefovir Dipivoxil—hepatitis B	0.00196	0.00584	CcSEcCtD
Mifepristone—Rash—Adefovir Dipivoxil—hepatitis B	0.00195	0.00579	CcSEcCtD
Mifepristone—Dermatitis—Adefovir Dipivoxil—hepatitis B	0.00195	0.00579	CcSEcCtD
Mifepristone—Headache—Adefovir Dipivoxil—hepatitis B	0.00194	0.00576	CcSEcCtD
Mifepristone—CYP3A7-CYP3A51P—liver—hepatitis B	0.00189	0.0485	CbGeAlD
Mifepristone—CYP3A7—Xenobiotics—CYP2A6—hepatitis B	0.00189	0.0227	CbGpPWpGaD
Mifepristone—Nausea—Entecavir—hepatitis B	0.00188	0.00559	CcSEcCtD
Mifepristone—Asthenia—Telbivudine—hepatitis B	0.00187	0.00555	CcSEcCtD
Mifepristone—Mediastinal disorder—Lamivudine—hepatitis B	0.00186	0.00553	CcSEcCtD
Mifepristone—Chills—Lamivudine—hepatitis B	0.00185	0.00551	CcSEcCtD
Mifepristone—Pruritus—Telbivudine—hepatitis B	0.00184	0.00547	CcSEcCtD
Mifepristone—AR—Nuclear Receptor transcription pathway—NR0B2—hepatitis B	0.00184	0.0221	CbGpPWpGaD
Mifepristone—Nausea—Adefovir Dipivoxil—hepatitis B	0.00183	0.00546	CcSEcCtD
Mifepristone—Malnutrition—Lamivudine—hepatitis B	0.0018	0.00534	CcSEcCtD
Mifepristone—Diarrhoea—Telbivudine—hepatitis B	0.00178	0.00529	CcSEcCtD
Mifepristone—Back pain—Lamivudine—hepatitis B	0.00174	0.00517	CcSEcCtD
Mifepristone—Muscle spasms—Lamivudine—hepatitis B	0.00173	0.00514	CcSEcCtD
Mifepristone—PGR—blood—hepatitis B	0.00172	0.0441	CbGeAlD
Mifepristone—Dizziness—Telbivudine—hepatitis B	0.00172	0.00512	CcSEcCtD
Mifepristone—PGR—Nuclear Receptor transcription pathway—HNF4A—hepatitis B	0.00167	0.0201	CbGpPWpGaD
Mifepristone—Ill-defined disorder—Lamivudine—hepatitis B	0.00167	0.00496	CcSEcCtD
Mifepristone—Vomiting—Telbivudine—hepatitis B	0.00165	0.00492	CcSEcCtD
Mifepristone—Angioedema—Lamivudine—hepatitis B	0.00164	0.00488	CcSEcCtD
Mifepristone—Rash—Telbivudine—hepatitis B	0.00164	0.00488	CcSEcCtD
Mifepristone—Dermatitis—Telbivudine—hepatitis B	0.00164	0.00487	CcSEcCtD
Mifepristone—Headache—Telbivudine—hepatitis B	0.00163	0.00485	CcSEcCtD
Mifepristone—ABCC1—Synthesis of Leukotrienes (LT) and Eoxins (EX)—GGT1—hepatitis B	0.00163	0.0196	CbGpPWpGaD
Mifepristone—Malaise—Lamivudine—hepatitis B	0.00162	0.00482	CcSEcCtD
Mifepristone—AR—Nuclear Receptors—HNF4A—hepatitis B	0.00161	0.0194	CbGpPWpGaD
Mifepristone—CYP2D6—CYP2E1 reactions—CYP2A6—hepatitis B	0.00157	0.0188	CbGpPWpGaD
Mifepristone—Nausea—Telbivudine—hepatitis B	0.00154	0.0046	CcSEcCtD
Mifepristone—Arthralgia—Lamivudine—hepatitis B	0.00153	0.00455	CcSEcCtD
Mifepristone—Myalgia—Lamivudine—hepatitis B	0.00153	0.00455	CcSEcCtD
Mifepristone—Anxiety—Lamivudine—hepatitis B	0.00152	0.00453	CcSEcCtD
Mifepristone—Unspecified disorder of skin and subcutaneous tissue—Lamivudine—hepatitis B	0.00152	0.00452	CcSEcCtD
Mifepristone—Discomfort—Lamivudine—hepatitis B	0.00151	0.00449	CcSEcCtD
Mifepristone—Dry mouth—Lamivudine—hepatitis B	0.0015	0.00445	CcSEcCtD
Mifepristone—Oedema—Lamivudine—hepatitis B	0.00147	0.00436	CcSEcCtD
Mifepristone—Infection—Lamivudine—hepatitis B	0.00146	0.00433	CcSEcCtD
Mifepristone—ABCB1—blood plasma—hepatitis B	0.00145	0.0372	CbGeAlD
Mifepristone—Nervous system disorder—Lamivudine—hepatitis B	0.00144	0.00428	CcSEcCtD
Mifepristone—Skin disorder—Lamivudine—hepatitis B	0.00142	0.00424	CcSEcCtD
Mifepristone—Anorexia—Lamivudine—hepatitis B	0.0014	0.00416	CcSEcCtD
Mifepristone—NR3C1—Nuclear Receptor transcription pathway—NR0B2—hepatitis B	0.00139	0.0167	CbGpPWpGaD
Mifepristone—AR—blood—hepatitis B	0.00137	0.0352	CbGeAlD
Mifepristone—Hypotension—Lamivudine—hepatitis B	0.00137	0.00407	CcSEcCtD
Mifepristone—CYP3A5—Xenobiotics—CYP2A6—hepatitis B	0.00137	0.0164	CbGpPWpGaD
Mifepristone—Musculoskeletal discomfort—Lamivudine—hepatitis B	0.00134	0.00397	CcSEcCtD
Mifepristone—Insomnia—Lamivudine—hepatitis B	0.00133	0.00394	CcSEcCtD
Mifepristone—CYP3A5—Tamoxifen metabolism—CYP2A6—hepatitis B	0.00132	0.0158	CbGpPWpGaD
Mifepristone—Dyspnoea—Lamivudine—hepatitis B	0.00131	0.00389	CcSEcCtD
Mifepristone—ABCC1—blood—hepatitis B	0.0013	0.0334	CbGeAlD
Mifepristone—Somnolence—Lamivudine—hepatitis B	0.0013	0.00388	CcSEcCtD
Mifepristone—Decreased appetite—Lamivudine—hepatitis B	0.00127	0.00379	CcSEcCtD
Mifepristone—AR—Nuclear Receptor transcription pathway—HNF4A—hepatitis B	0.00127	0.0153	CbGpPWpGaD
Mifepristone—Gastrointestinal disorder—Lamivudine—hepatitis B	0.00127	0.00376	CcSEcCtD
Mifepristone—Fatigue—Lamivudine—hepatitis B	0.00126	0.00376	CcSEcCtD
Mifepristone—Constipation—Lamivudine—hepatitis B	0.00125	0.00373	CcSEcCtD
Mifepristone—Pain—Lamivudine—hepatitis B	0.00125	0.00373	CcSEcCtD
Mifepristone—NR3C1—Nuclear Receptors—HNF4A—hepatitis B	0.00122	0.0147	CbGpPWpGaD
Mifepristone—Feeling abnormal—Lamivudine—hepatitis B	0.00121	0.00359	CcSEcCtD
Mifepristone—Gastrointestinal pain—Lamivudine—hepatitis B	0.0012	0.00357	CcSEcCtD
Mifepristone—AR—Androgen receptor signaling pathway—NR0B2—hepatitis B	0.00118	0.0141	CbGpPWpGaD
Mifepristone—Urticaria—Lamivudine—hepatitis B	0.00116	0.00346	CcSEcCtD
Mifepristone—CYP2D6—Fatty Acid Omega Oxidation—CYP2A6—hepatitis B	0.00116	0.014	CbGpPWpGaD
Mifepristone—Abdominal pain—Lamivudine—hepatitis B	0.00116	0.00345	CcSEcCtD
Mifepristone—Body temperature increased—Lamivudine—hepatitis B	0.00116	0.00345	CcSEcCtD
Mifepristone—CYP3A5—Aflatoxin activation and detoxification—GGT1—hepatitis B	0.00111	0.0134	CbGpPWpGaD
Mifepristone—CYP3A4—Aflatoxin activation and detoxification—GGT2—hepatitis B	0.00109	0.0131	CbGpPWpGaD
Mifepristone—NR3C1—FOXA2 and FOXA3 transcription factor networks—HNF4A—hepatitis B	0.00109	0.0131	CbGpPWpGaD
Mifepristone—Hypersensitivity—Lamivudine—hepatitis B	0.00108	0.00321	CcSEcCtD
Mifepristone—AR—liver—hepatitis B	0.00107	0.0275	CbGeAlD
Mifepristone—Asthenia—Lamivudine—hepatitis B	0.00105	0.00313	CcSEcCtD
Mifepristone—Pruritus—Lamivudine—hepatitis B	0.00104	0.00308	CcSEcCtD
Mifepristone—ABCC1—liver—hepatitis B	0.00102	0.0261	CbGeAlD
Mifepristone—CYP3A4—Farnesoid X Receptor  Pathway—NR0B2—hepatitis B	0.00102	0.0122	CbGpPWpGaD
Mifepristone—Diarrhoea—Lamivudine—hepatitis B	0.001	0.00298	CcSEcCtD
Mifepristone—CYP3A5—blood—hepatitis B	0.001	0.0257	CbGeAlD
Mifepristone—NR3C1—blood—hepatitis B	0.000995	0.0255	CbGeAlD
Mifepristone—CYP2D6—Xenobiotics—CYP2A6—hepatitis B	0.000973	0.0117	CbGpPWpGaD
Mifepristone—Dizziness—Lamivudine—hepatitis B	0.000969	0.00288	CcSEcCtD
Mifepristone—NR3C1—Nuclear Receptor transcription pathway—HNF4A—hepatitis B	0.000967	0.0116	CbGpPWpGaD
Mifepristone—AR—Integrated Breast Cancer Pathway—APOBEC3G—hepatitis B	0.000957	0.0115	CbGpPWpGaD
Mifepristone—CYP3A5—Constitutive Androstane Receptor Pathway—CYP2A6—hepatitis B	0.000939	0.0113	CbGpPWpGaD
Mifepristone—CYP2D6—Tamoxifen metabolism—CYP2A6—hepatitis B	0.000936	0.0112	CbGpPWpGaD
Mifepristone—Vomiting—Lamivudine—hepatitis B	0.000932	0.00277	CcSEcCtD
Mifepristone—Rash—Lamivudine—hepatitis B	0.000924	0.00275	CcSEcCtD
Mifepristone—Dermatitis—Lamivudine—hepatitis B	0.000923	0.00275	CcSEcCtD
Mifepristone—Headache—Lamivudine—hepatitis B	0.000918	0.00273	CcSEcCtD
Mifepristone—AR—Regulation of nuclear SMAD2/3 signaling—HNF4A—hepatitis B	0.00088	0.0106	CbGpPWpGaD
Mifepristone—Nausea—Lamivudine—hepatitis B	0.000871	0.00259	CcSEcCtD
Mifepristone—ABCC1—Arachidonic acid metabolism—GGT1—hepatitis B	0.000814	0.00977	CbGpPWpGaD
Mifepristone—CYP3A7—Cytochrome P450 - arranged by substrate type—CYP2A6—hepatitis B	0.000786	0.00943	CbGpPWpGaD
Mifepristone—CYP3A5—liver—hepatitis B	0.000784	0.0201	CbGeAlD
Mifepristone—NR3C1—liver—hepatitis B	0.000778	0.0199	CbGeAlD
Mifepristone—CYP3A7—Oxidation by Cytochrome P450—CYP2A6—hepatitis B	0.000776	0.00931	CbGpPWpGaD
Mifepristone—CYP3A4—Fatty Acid Omega Oxidation—CYP2A6—hepatitis B	0.00076	0.00913	CbGpPWpGaD
Mifepristone—PGR—Cellular roles of Anthrax toxin—TNF—hepatitis B	0.000755	0.00907	CbGpPWpGaD
Mifepristone—CYP3A4—blood—hepatitis B	0.000752	0.0193	CbGeAlD
Mifepristone—CYP2D6—blood—hepatitis B	0.00074	0.019	CbGeAlD
Mifepristone—ABCB1—Constitutive Androstane Receptor Pathway—CYP2A6—hepatitis B	0.000709	0.00851	CbGpPWpGaD
Mifepristone—AR—Regulation of nuclear SMAD2/3 signaling—IFNB1—hepatitis B	0.00069	0.00829	CbGpPWpGaD
Mifepristone—NR3C1—Adipogenesis—MIF—hepatitis B	0.000683	0.0082	CbGpPWpGaD
Mifepristone—NR3C1—Regulation of nuclear SMAD2/3 signaling—HNF4A—hepatitis B	0.000668	0.00801	CbGpPWpGaD
Mifepristone—ABCB1—Allograft Rejection—HLA-DPA1—hepatitis B	0.000655	0.00786	CbGpPWpGaD
Mifepristone—CYP3A7—Phase 1 - Functionalization of compounds—CYP2A6—hepatitis B	0.000637	0.00765	CbGpPWpGaD
Mifepristone—CYP3A4—Xenobiotics—CYP2A6—hepatitis B	0.000636	0.00764	CbGpPWpGaD
Mifepristone—CYP3A4—Tamoxifen metabolism—CYP2A6—hepatitis B	0.000612	0.00734	CbGpPWpGaD
Mifepristone—CYP3A4—liver—hepatitis B	0.000588	0.0151	CbGeAlD
Mifepristone—CYP2D6—liver—hepatitis B	0.000579	0.0148	CbGeAlD
Mifepristone—CYP3A7—Metapathway biotransformation—AKR1B1—hepatitis B	0.000575	0.0069	CbGpPWpGaD
Mifepristone—CYP3A5—Cytochrome P450 - arranged by substrate type—CYP2A6—hepatitis B	0.000568	0.00682	CbGpPWpGaD
Mifepristone—CYP3A5—Oxidation by Cytochrome P450—CYP2A6—hepatitis B	0.000561	0.00673	CbGpPWpGaD
Mifepristone—CYP3A7—Biological oxidations—GGT2—hepatitis B	0.000559	0.00671	CbGpPWpGaD
Mifepristone—AR—Regulation of nuclear SMAD2/3 signaling—IL10—hepatitis B	0.000533	0.0064	CbGpPWpGaD
Mifepristone—ABCB1—blood—hepatitis B	0.000533	0.0136	CbGeAlD
Mifepristone—NR3C1—Regulation of nuclear SMAD2/3 signaling—IFNB1—hepatitis B	0.000524	0.00629	CbGpPWpGaD
Mifepristone—CYP3A4—Aflatoxin activation and detoxification—GGT1—hepatitis B	0.000517	0.00621	CbGpPWpGaD
Mifepristone—NR3C1—FOXA2 and FOXA3 transcription factor networks—F2—hepatitis B	0.000511	0.00614	CbGpPWpGaD
Mifepristone—AR—Notch-mediated HES/HEY network—CD4—hepatitis B	0.000468	0.00562	CbGpPWpGaD
Mifepristone—CYP3A5—Phase 1 - Functionalization of compounds—CYP2A6—hepatitis B	0.000461	0.00553	CbGpPWpGaD
Mifepristone—NR3C1—AP-1 transcription factor network—IL10—hepatitis B	0.000455	0.00546	CbGpPWpGaD
Mifepristone—AR—Integrated Pancreatic Cancer Pathway—HNF4A—hepatitis B	0.000443	0.00532	CbGpPWpGaD
Mifepristone—CYP3A4—Constitutive Androstane Receptor Pathway—CYP2A6—hepatitis B	0.000437	0.00524	CbGpPWpGaD
Mifepristone—NR3C1—Transcription factor regulation in adipogenesis—TNF—hepatitis B	0.000437	0.00524	CbGpPWpGaD
Mifepristone—NR3C1—FOXA2 and FOXA3 transcription factor networks—ALB—hepatitis B	0.000425	0.0051	CbGpPWpGaD
Mifepristone—ABCB1—HIF-1-alpha transcription factor network—HNF4A—hepatitis B	0.000422	0.00507	CbGpPWpGaD
Mifepristone—PGR—Generic Transcription Pathway—NR0B2—hepatitis B	0.000417	0.005	CbGpPWpGaD
Mifepristone—ABCB1—liver—hepatitis B	0.000416	0.0107	CbGeAlD
Mifepristone—CYP3A5—Metapathway biotransformation—AKR1B1—hepatitis B	0.000415	0.00499	CbGpPWpGaD
Mifepristone—NR3C1—Regulation of nuclear SMAD2/3 signaling—IL10—hepatitis B	0.000404	0.00486	CbGpPWpGaD
Mifepristone—CYP2D6—Cytochrome P450 - arranged by substrate type—CYP2A6—hepatitis B	0.000404	0.00485	CbGpPWpGaD
Mifepristone—CYP3A5—Biological oxidations—GGT2—hepatitis B	0.000404	0.00485	CbGpPWpGaD
Mifepristone—AR—Coregulation of Androgen receptor activity—CDKN2A—hepatitis B	0.000403	0.00484	CbGpPWpGaD
Mifepristone—NR3C1—AP-1 transcription factor network—HLA-A—hepatitis B	0.000401	0.00481	CbGpPWpGaD
Mifepristone—CYP2D6—Oxidation by Cytochrome P450—CYP2A6—hepatitis B	0.000399	0.00479	CbGpPWpGaD
Mifepristone—NR3C1—Transcription factor regulation in adipogenesis—IL6—hepatitis B	0.000352	0.00423	CbGpPWpGaD
Mifepristone—CYP3A7—Biological oxidations—CYP2A6—hepatitis B	0.000338	0.00406	CbGpPWpGaD
Mifepristone—AR—Coregulation of Androgen receptor activity—CTNNB1—hepatitis B	0.000337	0.00405	CbGpPWpGaD
Mifepristone—CYP2D6—Phase 1 - Functionalization of compounds—CYP2A6—hepatitis B	0.000327	0.00393	CbGpPWpGaD
Mifepristone—AR—Regulation of nuclear beta catenin signaling and target gene transcription—CDKN2A—hepatitis B	0.000325	0.0039	CbGpPWpGaD
Mifepristone—AR—Generic Transcription Pathway—NR0B2—hepatitis B	0.000317	0.00381	CbGpPWpGaD
Mifepristone—AR—SIDS Susceptibility Pathways—IL10—hepatitis B	0.000316	0.00379	CbGpPWpGaD
Mifepristone—ABCB1—Allograft Rejection—HLA-DPB1—hepatitis B	0.000301	0.00361	CbGpPWpGaD
Mifepristone—CYP2D6—Metapathway biotransformation—AKR1B1—hepatitis B	0.000295	0.00355	CbGpPWpGaD
Mifepristone—PGR—Generic Transcription Pathway—HNF4A—hepatitis B	0.000289	0.00347	CbGpPWpGaD
Mifepristone—CYP2D6—Biological oxidations—GGT2—hepatitis B	0.000287	0.00345	CbGpPWpGaD
Mifepristone—NR3C1—AP-1 transcription factor network—CDKN2A—hepatitis B	0.000274	0.00329	CbGpPWpGaD
Mifepristone—AR—Regulation of nuclear beta catenin signaling and target gene transcription—CTNNB1—hepatitis B	0.000272	0.00326	CbGpPWpGaD
Mifepristone—NR3C1—AP-1 transcription factor network—IFNG—hepatitis B	0.000267	0.00321	CbGpPWpGaD
Mifepristone—CYP3A7—Biological oxidations—GGT1—hepatitis B	0.000264	0.00317	CbGpPWpGaD
Mifepristone—CYP3A4—Cytochrome P450 - arranged by substrate type—CYP2A6—hepatitis B	0.000264	0.00317	CbGpPWpGaD
Mifepristone—AR—Regulation of nuclear SMAD2/3 signaling—CDKN1A—hepatitis B	0.000263	0.00315	CbGpPWpGaD
Mifepristone—CYP3A4—Oxidation by Cytochrome P450—CYP2A6—hepatitis B	0.000261	0.00313	CbGpPWpGaD
Mifepristone—ABCC1—Metabolism of lipids and lipoproteins—AKR1B1—hepatitis B	0.000257	0.00308	CbGpPWpGaD
Mifepristone—AR—Integrated Pancreatic Cancer Pathway—FASLG—hepatitis B	0.00025	0.003	CbGpPWpGaD
Mifepristone—AR—Androgen receptor signaling pathway—CTNNB1—hepatitis B	0.000249	0.00299	CbGpPWpGaD
Mifepristone—NR3C1—Adipogenesis—FAS—hepatitis B	0.000248	0.00298	CbGpPWpGaD
Mifepristone—CYP3A5—Biological oxidations—CYP2A6—hepatitis B	0.000245	0.00294	CbGpPWpGaD
Mifepristone—AR—Androgen receptor signaling pathway—CDKN1A—hepatitis B	0.000244	0.00292	CbGpPWpGaD
Mifepristone—AR—Androgen receptor signaling pathway—PTEN—hepatitis B	0.000243	0.00292	CbGpPWpGaD
Mifepristone—NR3C1—Generic Transcription Pathway—NR0B2—hepatitis B	0.000241	0.00289	CbGpPWpGaD
Mifepristone—AR—Integrated Pancreatic Cancer Pathway—FAS—hepatitis B	0.000241	0.00289	CbGpPWpGaD
Mifepristone—NR3C1—SIDS Susceptibility Pathways—IL10—hepatitis B	0.000239	0.00287	CbGpPWpGaD
Mifepristone—NR3C1—AP-1 transcription factor network—IL2—hepatitis B	0.000238	0.00285	CbGpPWpGaD
Mifepristone—NR3C1—Glucocorticoid receptor regulatory network—IFNG—hepatitis B	0.000236	0.00283	CbGpPWpGaD
Mifepristone—NR3C1—Endoderm Differentiation—CTNNB1—hepatitis B	0.000235	0.00282	CbGpPWpGaD
Mifepristone—NR3C1—AP-1 transcription factor network—CTNNB1—hepatitis B	0.000229	0.00275	CbGpPWpGaD
Mifepristone—CYP2D6—Melatonin metabolism and effects—NFKB1—hepatitis B	0.000228	0.00274	CbGpPWpGaD
Mifepristone—NR3C1—AP-1 transcription factor network—PTEN—hepatitis B	0.000223	0.00268	CbGpPWpGaD
Mifepristone—ABCB1—Allograft Rejection—IL10—hepatitis B	0.000222	0.00266	CbGpPWpGaD
Mifepristone—ABCB1—Allograft Rejection—CD40LG—hepatitis B	0.000222	0.00266	CbGpPWpGaD
Mifepristone—AR—Generic Transcription Pathway—HNF4A—hepatitis B	0.00022	0.00264	CbGpPWpGaD
Mifepristone—CYP3A4—Phase 1 - Functionalization of compounds—CYP2A6—hepatitis B	0.000214	0.00257	CbGpPWpGaD
Mifepristone—NR3C1—Glucocorticoid receptor regulatory network—IL2—hepatitis B	0.000209	0.00251	CbGpPWpGaD
Mifepristone—PGR—Signaling by ERBB4—CDKN1A—hepatitis B	0.000208	0.0025	CbGpPWpGaD
Mifepristone—PGR—Signaling by ERBB4—PTEN—hepatitis B	0.000208	0.0025	CbGpPWpGaD
Mifepristone—ABCB1—Allograft Rejection—FASLG—hepatitis B	0.000206	0.00247	CbGpPWpGaD
Mifepristone—PGR—Gene Expression—NR0B2—hepatitis B	0.000201	0.00241	CbGpPWpGaD
Mifepristone—NR3C1—Regulation of nuclear SMAD2/3 signaling—CDKN1A—hepatitis B	0.000199	0.00239	CbGpPWpGaD
Mifepristone—ABCB1—Allograft Rejection—FAS—hepatitis B	0.000199	0.00239	CbGpPWpGaD
Mifepristone—NR3C1—Glucocorticoid receptor regulatory network—CDKN1A—hepatitis B	0.000197	0.00237	CbGpPWpGaD
Mifepristone—ABCB1—HIF-1-alpha transcription factor network—NOS2—hepatitis B	0.000196	0.00236	CbGpPWpGaD
Mifepristone—NR3C1—Glucocorticoid receptor regulatory network—NFKB1—hepatitis B	0.000196	0.00235	CbGpPWpGaD
Mifepristone—ABCB1—Allograft Rejection—HLA-A—hepatitis B	0.000195	0.00235	CbGpPWpGaD
Mifepristone—CYP3A4—Metapathway biotransformation—AKR1B1—hepatitis B	0.000193	0.00232	CbGpPWpGaD
Mifepristone—CYP3A5—Biological oxidations—GGT1—hepatitis B	0.000191	0.00229	CbGpPWpGaD
Mifepristone—NR3C1—Endoderm Differentiation—TGFB1—hepatitis B	0.00019	0.00228	CbGpPWpGaD
Mifepristone—CYP3A4—Biological oxidations—GGT2—hepatitis B	0.000188	0.00225	CbGpPWpGaD
Mifepristone—NR3C1—AP-1 transcription factor network—TGFB1—hepatitis B	0.000185	0.00222	CbGpPWpGaD
Mifepristone—ABCB1—Integrated Pancreatic Cancer Pathway—HNF4A—hepatitis B	0.000181	0.00217	CbGpPWpGaD
Mifepristone—ABCB1—Allograft Rejection—HLA-DRB1—hepatitis B	0.000178	0.00214	CbGpPWpGaD
Mifepristone—CYP2D6—Biological oxidations—CYP2A6—hepatitis B	0.000174	0.00209	CbGpPWpGaD
Mifepristone—NR3C1—Generic Transcription Pathway—HNF4A—hepatitis B	0.000167	0.002	CbGpPWpGaD
Mifepristone—AR—Integrated Breast Cancer Pathway—CTNNB1—hepatitis B	0.000163	0.00196	CbGpPWpGaD
Mifepristone—PGR—Signaling Pathways—SAG—hepatitis B	0.000162	0.00194	CbGpPWpGaD
Mifepristone—PGR—Signaling Pathways—RIT2—hepatitis B	0.000162	0.00194	CbGpPWpGaD
Mifepristone—AR—Integrated Breast Cancer Pathway—PTEN—hepatitis B	0.000159	0.00191	CbGpPWpGaD
Mifepristone—AR—SIDS Susceptibility Pathways—CTNNB1—hepatitis B	0.000159	0.00191	CbGpPWpGaD
Mifepristone—AR—Integrated Breast Cancer Pathway—NFKB1—hepatitis B	0.000158	0.0019	CbGpPWpGaD
Mifepristone—AR—SIDS Susceptibility Pathways—NFKB1—hepatitis B	0.000154	0.00185	CbGpPWpGaD
Mifepristone—AR—Gene Expression—NR0B2—hepatitis B	0.000153	0.00183	CbGpPWpGaD
Mifepristone—NR3C1—AP-1 transcription factor network—TP53—hepatitis B	0.000153	0.00183	CbGpPWpGaD
Mifepristone—ABCC1—Disease—APOBEC3G—hepatitis B	0.000151	0.00181	CbGpPWpGaD
Mifepristone—ABCC1—Disease—SAG—hepatitis B	0.000151	0.00181	CbGpPWpGaD
Mifepristone—NR3C1—Adipogenesis—CTNNB1—hepatitis B	0.00014	0.00168	CbGpPWpGaD
Mifepristone—NR3C1—AP-1 transcription factor network—IL6—hepatitis B	0.00014	0.00168	CbGpPWpGaD
Mifepristone—PGR—Gene Expression—HNF4A—hepatitis B	0.000139	0.00167	CbGpPWpGaD
Mifepristone—NR3C1—Adipogenesis—CDKN1A—hepatitis B	0.000137	0.00164	CbGpPWpGaD
Mifepristone—CYP2D6—Biological oxidations—GGT1—hepatitis B	0.000136	0.00163	CbGpPWpGaD
Mifepristone—AR—Integrated Pancreatic Cancer Pathway—CTNNB1—hepatitis B	0.000135	0.00163	CbGpPWpGaD
Mifepristone—NR3C1—Glucocorticoid receptor regulatory network—TP53—hepatitis B	0.000134	0.00161	CbGpPWpGaD
Mifepristone—AR—Integrated Pancreatic Cancer Pathway—CDKN1A—hepatitis B	0.000132	0.00159	CbGpPWpGaD
Mifepristone—AR—Integrated Pancreatic Cancer Pathway—PTEN—hepatitis B	0.000132	0.00158	CbGpPWpGaD
Mifepristone—AR—Integrated Pancreatic Cancer Pathway—NFKB1—hepatitis B	0.000131	0.00158	CbGpPWpGaD
Mifepristone—ABCB1—Allograft Rejection—IFNG—hepatitis B	0.00013	0.00156	CbGpPWpGaD
Mifepristone—PGR—Signaling by ERBB4—IL6—hepatitis B	0.00013	0.00156	CbGpPWpGaD
Mifepristone—NR3C1—Glucocorticoid receptor regulatory network—IL6—hepatitis B	0.000123	0.00148	CbGpPWpGaD
Mifepristone—NR3C1—SIDS Susceptibility Pathways—CTNNB1—hepatitis B	0.000121	0.00145	CbGpPWpGaD
Mifepristone—AR—SIDS Susceptibility Pathways—TNF—hepatitis B	0.00012	0.00144	CbGpPWpGaD
Mifepristone—NR3C1—SIDS Susceptibility Pathways—NFKB1—hepatitis B	0.000117	0.00141	CbGpPWpGaD
Mifepristone—ABCC1—Metabolism of lipids and lipoproteins—GGT1—hepatitis B	0.000116	0.0014	CbGpPWpGaD
Mifepristone—NR3C1—Gene Expression—NR0B2—hepatitis B	0.000116	0.00139	CbGpPWpGaD
Mifepristone—ABCB1—Allograft Rejection—IL2—hepatitis B	0.000116	0.00139	CbGpPWpGaD
Mifepristone—ABCC1—Metabolism—AKR1B1—hepatitis B	0.000114	0.00137	CbGpPWpGaD
Mifepristone—CYP3A4—Biological oxidations—CYP2A6—hepatitis B	0.000114	0.00137	CbGpPWpGaD
Mifepristone—NR3C1—Adipogenesis—TGFB1—hepatitis B	0.000113	0.00136	CbGpPWpGaD
Mifepristone—ABCC1—Metabolism—GGT2—hepatitis B	0.00011	0.00131	CbGpPWpGaD
Mifepristone—AR—Integrated Pancreatic Cancer Pathway—TGFB1—hepatitis B	0.000109	0.00131	CbGpPWpGaD
Mifepristone—AR—Integrated Breast Cancer Pathway—TP53—hepatitis B	0.000109	0.0013	CbGpPWpGaD
Mifepristone—AR—Gene Expression—HNF4A—hepatitis B	0.000106	0.00127	CbGpPWpGaD
Mifepristone—NR3C1—Adipogenesis—TNF—hepatitis B	0.000105	0.00127	CbGpPWpGaD
Mifepristone—AR—Integrated Pancreatic Cancer Pathway—TNF—hepatitis B	0.000102	0.00123	CbGpPWpGaD
Mifepristone—ABCB1—Integrated Pancreatic Cancer Pathway—FASLG—hepatitis B	0.000102	0.00122	CbGpPWpGaD
Mifepristone—CYP3A7—Metabolism—AKR1B1—hepatitis B	9.96e-05	0.0012	CbGpPWpGaD
Mifepristone—ABCB1—Integrated Pancreatic Cancer Pathway—FAS—hepatitis B	9.81e-05	0.00118	CbGpPWpGaD
Mifepristone—AR—SIDS Susceptibility Pathways—IL6—hepatitis B	9.69e-05	0.00116	CbGpPWpGaD
Mifepristone—CYP3A7—Metabolism—GGT2—hepatitis B	9.55e-05	0.00115	CbGpPWpGaD
Mifepristone—NR3C1—SIDS Susceptibility Pathways—TNF—hepatitis B	9.11e-05	0.00109	CbGpPWpGaD
Mifepristone—ABCB1—Allograft Rejection—TGFB1—hepatitis B	9.03e-05	0.00108	CbGpPWpGaD
Mifepristone—AR—Integrated Pancreatic Cancer Pathway—TP53—hepatitis B	9.01e-05	0.00108	CbGpPWpGaD
Mifepristone—CYP3A4—Biological oxidations—GGT1—hepatitis B	8.88e-05	0.00107	CbGpPWpGaD
Mifepristone—NR3C1—Adipogenesis—IL6—hepatitis B	8.51e-05	0.00102	CbGpPWpGaD
Mifepristone—ABCB1—Allograft Rejection—TNF—hepatitis B	8.44e-05	0.00101	CbGpPWpGaD
Mifepristone—NR3C1—Gene Expression—HNF4A—hepatitis B	8.04e-05	0.000965	CbGpPWpGaD
Mifepristone—NR3C1—SIDS Susceptibility Pathways—IL6—hepatitis B	7.35e-05	0.000883	CbGpPWpGaD
Mifepristone—CYP3A5—Metabolism—AKR1B1—hepatitis B	7.2e-05	0.000865	CbGpPWpGaD
Mifepristone—ABCC1—Disease—GOT2—hepatitis B	7.17e-05	0.00086	CbGpPWpGaD
Mifepristone—CYP3A5—Metabolism—GGT2—hepatitis B	6.91e-05	0.000829	CbGpPWpGaD
Mifepristone—ABCC1—Metabolism—CYP2A6—hepatitis B	6.64e-05	0.000797	CbGpPWpGaD
Mifepristone—PGR—Signaling Pathways—CXCL10—hepatitis B	6.39e-05	0.000767	CbGpPWpGaD
Mifepristone—ABCC1—Metabolism of lipids and lipoproteins—ALB—hepatitis B	6.19e-05	0.000743	CbGpPWpGaD
Mifepristone—ABCC1—Disease—GOT1—hepatitis B	6.19e-05	0.000743	CbGpPWpGaD
Mifepristone—ABCC1—Metabolism—GOT2—hepatitis B	6e-05	0.00072	CbGpPWpGaD
Mifepristone—ABCC1—Transmembrane transport of small molecules—ALB—hepatitis B	5.88e-05	0.000706	CbGpPWpGaD
Mifepristone—CYP3A7—Metabolism—CYP2A6—hepatitis B	5.79e-05	0.000695	CbGpPWpGaD
Mifepristone—ABCB1—Integrated Pancreatic Cancer Pathway—CTNNB1—hepatitis B	5.52e-05	0.000662	CbGpPWpGaD
Mifepristone—ABCB1—Metabolism—AKR1B1—hepatitis B	5.43e-05	0.000652	CbGpPWpGaD
Mifepristone—ABCB1—Integrated Pancreatic Cancer Pathway—CDKN1A—hepatitis B	5.39e-05	0.000647	CbGpPWpGaD
Mifepristone—ABCB1—Integrated Pancreatic Cancer Pathway—PTEN—hepatitis B	5.38e-05	0.000646	CbGpPWpGaD
Mifepristone—ABCB1—Integrated Pancreatic Cancer Pathway—NFKB1—hepatitis B	5.35e-05	0.000643	CbGpPWpGaD
Mifepristone—CYP3A7—Metabolism—GOT2—hepatitis B	5.23e-05	0.000628	CbGpPWpGaD
Mifepristone—ABCB1—Metabolism—GGT2—hepatitis B	5.21e-05	0.000626	CbGpPWpGaD
Mifepristone—ABCC1—Metabolism—GGT1—hepatitis B	5.18e-05	0.000622	CbGpPWpGaD
Mifepristone—ABCC1—Metabolism—GOT1—hepatitis B	5.18e-05	0.000622	CbGpPWpGaD
Mifepristone—CYP2D6—Metabolism—AKR1B1—hepatitis B	5.12e-05	0.000615	CbGpPWpGaD
Mifepristone—PGR—Signaling Pathways—CCR5—hepatitis B	4.95e-05	0.000595	CbGpPWpGaD
Mifepristone—CYP2D6—Metabolism—GGT2—hepatitis B	4.91e-05	0.000589	CbGpPWpGaD
Mifepristone—ABCC1—Metabolism of lipids and lipoproteins—PTEN—hepatitis B	4.72e-05	0.000567	CbGpPWpGaD
Mifepristone—ABCC1—Disease—CCR5—hepatitis B	4.62e-05	0.000554	CbGpPWpGaD
Mifepristone—CYP3A7—Metabolism—GGT1—hepatitis B	4.52e-05	0.000542	CbGpPWpGaD
Mifepristone—CYP3A7—Metabolism—GOT1—hepatitis B	4.52e-05	0.000542	CbGpPWpGaD
Mifepristone—ABCC1—Disease—HLA-A—hepatitis B	4.5e-05	0.00054	CbGpPWpGaD
Mifepristone—ABCB1—Integrated Pancreatic Cancer Pathway—TGFB1—hepatitis B	4.46e-05	0.000535	CbGpPWpGaD
Mifepristone—PGR—Signaling Pathways—F2—hepatitis B	4.25e-05	0.00051	CbGpPWpGaD
Mifepristone—CYP3A5—Metabolism—CYP2A6—hepatitis B	4.18e-05	0.000502	CbGpPWpGaD
Mifepristone—ABCB1—Integrated Pancreatic Cancer Pathway—TNF—hepatitis B	4.16e-05	0.0005	CbGpPWpGaD
Mifepristone—ABCC1—Disease—NOS2—hepatitis B	3.91e-05	0.00047	CbGpPWpGaD
Mifepristone—CYP3A5—Metabolism—GOT2—hepatitis B	3.78e-05	0.000454	CbGpPWpGaD
Mifepristone—ABCB1—Integrated Pancreatic Cancer Pathway—TP53—hepatitis B	3.67e-05	0.000441	CbGpPWpGaD
Mifepristone—CYP3A4—Metabolism—AKR1B1—hepatitis B	3.35e-05	0.000402	CbGpPWpGaD
Mifepristone—CYP3A5—Metabolism—GOT1—hepatitis B	3.27e-05	0.000392	CbGpPWpGaD
Mifepristone—CYP3A5—Metabolism—GGT1—hepatitis B	3.27e-05	0.000392	CbGpPWpGaD
Mifepristone—CYP3A4—Metabolism—GGT2—hepatitis B	3.21e-05	0.000385	CbGpPWpGaD
Mifepristone—ABCB1—Metabolism—CYP2A6—hepatitis B	3.16e-05	0.000379	CbGpPWpGaD
Mifepristone—CYP2D6—Metabolism—CYP2A6—hepatitis B	2.97e-05	0.000357	CbGpPWpGaD
Mifepristone—ABCC1—Disease—CD4—hepatitis B	2.9e-05	0.000348	CbGpPWpGaD
Mifepristone—PGR—Signaling Pathways—IL2—hepatitis B	2.86e-05	0.000344	CbGpPWpGaD
Mifepristone—ABCB1—Metabolism—GOT2—hepatitis B	2.86e-05	0.000343	CbGpPWpGaD
Mifepristone—ABCB1—Transmembrane transport of small molecules—ALB—hepatitis B	2.8e-05	0.000336	CbGpPWpGaD
Mifepristone—PGR—Signaling Pathways—CTNNB1—hepatitis B	2.76e-05	0.000332	CbGpPWpGaD
Mifepristone—ABCC1—Metabolism—ALB—hepatitis B	2.76e-05	0.000331	CbGpPWpGaD
Mifepristone—PGR—Signaling Pathways—CDKN1A—hepatitis B	2.7e-05	0.000324	CbGpPWpGaD
Mifepristone—PGR—Signaling Pathways—PTEN—hepatitis B	2.69e-05	0.000323	CbGpPWpGaD
Mifepristone—CYP2D6—Metabolism—GOT2—hepatitis B	2.69e-05	0.000323	CbGpPWpGaD
Mifepristone—PGR—Signaling Pathways—NFKB1—hepatitis B	2.68e-05	0.000322	CbGpPWpGaD
Mifepristone—ABCC1—Disease—CTNNB1—hepatitis B	2.58e-05	0.000309	CbGpPWpGaD
Mifepristone—ABCC1—Disease—CDKN1A—hepatitis B	2.52e-05	0.000302	CbGpPWpGaD
Mifepristone—ABCC1—Disease—PTEN—hepatitis B	2.51e-05	0.000301	CbGpPWpGaD
Mifepristone—ABCB1—Metabolism—GGT1—hepatitis B	2.46e-05	0.000296	CbGpPWpGaD
Mifepristone—ABCB1—Metabolism—GOT1—hepatitis B	2.46e-05	0.000296	CbGpPWpGaD
Mifepristone—CYP3A7—Metabolism—ALB—hepatitis B	2.4e-05	0.000289	CbGpPWpGaD
Mifepristone—CYP2D6—Metabolism—GGT1—hepatitis B	2.32e-05	0.000279	CbGpPWpGaD
Mifepristone—CYP2D6—Metabolism—GOT1—hepatitis B	2.32e-05	0.000279	CbGpPWpGaD
Mifepristone—PGR—Signaling Pathways—TGFB1—hepatitis B	2.23e-05	0.000268	CbGpPWpGaD
Mifepristone—ABCC1—Metabolism—PTEN—hepatitis B	2.1e-05	0.000252	CbGpPWpGaD
Mifepristone—ABCC1—Disease—TGFB1—hepatitis B	2.08e-05	0.00025	CbGpPWpGaD
Mifepristone—CYP3A4—Metabolism—CYP2A6—hepatitis B	1.95e-05	0.000233	CbGpPWpGaD
Mifepristone—PGR—Signaling Pathways—TP53—hepatitis B	1.84e-05	0.000221	CbGpPWpGaD
Mifepristone—CYP3A7—Metabolism—PTEN—hepatitis B	1.83e-05	0.00022	CbGpPWpGaD
Mifepristone—CYP3A4—Metabolism—GOT2—hepatitis B	1.76e-05	0.000211	CbGpPWpGaD
Mifepristone—CYP3A5—Metabolism—ALB—hepatitis B	1.74e-05	0.000209	CbGpPWpGaD
Mifepristone—PGR—Signaling Pathways—IL6—hepatitis B	1.68e-05	0.000202	CbGpPWpGaD
Mifepristone—ABCC1—Disease—IL6—hepatitis B	1.57e-05	0.000188	CbGpPWpGaD
Mifepristone—CYP3A4—Metabolism—GOT1—hepatitis B	1.52e-05	0.000182	CbGpPWpGaD
Mifepristone—CYP3A4—Metabolism—GGT1—hepatitis B	1.52e-05	0.000182	CbGpPWpGaD
Mifepristone—CYP3A5—Metabolism—PTEN—hepatitis B	1.33e-05	0.000159	CbGpPWpGaD
Mifepristone—ABCB1—Metabolism—ALB—hepatitis B	1.31e-05	0.000157	CbGpPWpGaD
Mifepristone—CYP2D6—Metabolism—ALB—hepatitis B	1.24e-05	0.000148	CbGpPWpGaD
Mifepristone—ABCB1—Metabolism—PTEN—hepatitis B	1e-05	0.00012	CbGpPWpGaD
Mifepristone—CYP2D6—Metabolism—PTEN—hepatitis B	9.43e-06	0.000113	CbGpPWpGaD
Mifepristone—CYP3A4—Metabolism—ALB—hepatitis B	8.08e-06	9.7e-05	CbGpPWpGaD
Mifepristone—CYP3A4—Metabolism—PTEN—hepatitis B	6.16e-06	7.4e-05	CbGpPWpGaD
